AIQ Limited
17 August 2026
17 August 2026
AIQ Limited
("AIQ" or the "Company")
Update on Convertible Loan Note Instrument
Further to the Company's announcement of 6 July 2026, AIQ (LSE: AIQ) is pleased to announce that, on 14 August 2026, it issued further convertible loan notes of £250k to new noteholders under its convertible loan note instrument with China International Securities Ltd that was entered into on 3 July 2026 (the "New Loan Note Facility"). To date, the Company has issued convertible loan notes totalling £1.25m under the New Loan Facility.
The remaining loan notes of up to £750k to be issued under the New Loan Note Facility may be issued in tranches up to and including 31 August 2026. This follows the Board signing, on 14 August 2026, a deed of variation to extend the deadline for the issue of convertible loan notes under the New Loan Note Facility from 14 August 2026 to 31 August 2026 to allow sufficient time for satisfactory KYC and AML being carried out on proposed new noteholders that have pledged a total of £500k.
All other details of the New Loan Facility remain unchanged and are as set out in the Company's announcement of 6 July 2026.
Enquiries
|
AIQ Limited |
c/o +44 (0)20 4582 3500 |
|
Harry Chathli, Chairman |
|
|
Guild Financial Advisory Limited (Financial Adviser) |
+44 (0)7973839767 |
|
Ross Andrews |
|
|
Gracechurch Group (Financial PR) |
+44 (0)20 4582 3500 |
|
Claire Norbury |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.